Connect with Tandem t:slim X2™ Insulin Pump
Tested. Trusted. Better. Tandem t:slimX2 insulin pump.
The t:slim X2 insulin pump is now powered by Control-IQ+ technology —the only predictive algorithm with AutoBolus. The best Tandem algorithm ever pairs with Dexcom's most accurate CGM2-3, to predict and help prevent highs and lows for more time in range. Now available for ages 2+.
Trusted partners in diabetes management
On a Tandem t:slim X2TM AID system, Dexcom patients experience 11% more time in range. That's more than 2.6 hours a day!1
Control-IQ+ Technology
Control-IQ+ offers unique and enhanced features for more targeted control. It includes a 30-minute prediction and automatically adjusts insulin delivery every 5-minutes to help protect from highs and lows with zero fingersticks.* Now available for ages 2+.
*Fingersticks required for diabetes treatment decision if symptoms or expectations do not match readings.
Sleep Activity Setting
Only Tandem pumps have a dedicated Sleep Activity, which is designed to help protect from overnight lows and morning highs with fewer disruptions from alerts and alarms.
AutoBolus
AutoBolus* is designed to help prevent highs and cover missed meal boluses.
* If glucose values are predicted to be above 180 mg/dL (or 10.0 mmol/L), Control-IQ+ technology calculates a correction bolus using the Personal Profile settings and a target of 110 mg/dL (or 6.1 mmol/L) and delivers 60% of that value.
A perfect pairing
Dexcom and Tandem have created life-changing1 diabetes management solutions with nearly a decade of collaboration.
Dexcom G7
- The most accurate CGM system2,3
- The only CGM that offers no fingersticks* from day 1
- 60% smaller§
- The fastest CGM - 30-minute warmup||
- The only CGM with an Urgent Low Soon alert¶, notifying patients of a severe low up to 20 minutes before it happens
*Fingersticks required for diabetes treatment decision if symptoms or expectations do not match readings. ¶ Audible and visual notification of predictive alert at 55 mg/dL within 20 minutes.
t:slim X2 insulin pump
- Control-IQ+ technology with AutoBolus is designed to prevent highs and cover missed meal boluses
- User-friendly, all-in-one system with a color touchscreen
- Holds up to 300 units of insulin
Meet Dexcom CGM
With Dexcom CGM, you have the option to choose the insulin pump that works best for you. Glucose readings are sent to your smartphone‡ or Dexcom receiver—without fingersticks.*
*Fingersticks required for diabetes treatment decision if symptoms or expectations do not match readings.
Do you have questions about the t:slim X2 insulin pump?
Our experts are here to help.
†Bolus delivery from the t:connect mobile app requires a compatible smartphone model and operating system, an app update, a remote software update on the customer’s t:slim X2 insulin pump and additional training. Only available to Tandem Diabetes Care customers who reside in the United States. ‡For a list of compatible devices, visit dexcom.com/compatibility. §Compared to prior generation Dexcom CGM system. ||Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.
1 Brown SA, et al. N Engl J Med. 2019;381(18):1707-1717. 2 U.S. Food and Drug Administration, 510(k) Substantial Equivalence Determination Decision Summary, K213919. Published December 7, 2022. https://www.accessdata.fda.gov/cdrh_docs/reviews/K213919.pdf. 3 U.S. Food and Drug Administration, 510(k) Substantial Equivalence Determination Decision Summary, K222447. Published March 3, 2023. https://www.accessdata.fda.gov/cdrh_docs/reviews/K222447.pdf.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.
RX ONLY. The t:slim X2 pump with interoperable technology (the pump) and Control-IQ+ technology (Control-IQ+) are intended for single patient use. The pump and Control-IQ+ are indicated for use with NovoLog or Humalog U-100 insulin. t:slim X2 insulin pump: The pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater. Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater. and greater. Control-IQ+ technology is intended for single patient use. Control-IQ+ technology is indicated for use with NovoLog or Humalog U-100 insulin.
WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control -IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.